Press Releases April 17, 2026 09:32 AM

The York Water Company Announces Closing of Its Common Stock Public Offering

The York Water Company completes public offering raising $41.4 million for corporate uses

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
YORW

The York Water Company has closed its public offering of 1,521,739 common shares at $28.50 per share, raising net proceeds of approximately $41.4 million. The funds are intended for general corporate purposes, including capital investments, debt repayment, and potential acquisitions. The offering was managed by Huntington Capital Markets and Seaport Global Securities and involves a filed prospectus supplement with the SEC.

The York Water Company Announces Closing of Its Common Stock Public Offering
YORW
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The company raised $41.4 million net through the offering of common stock.
  • Proceeds will be used for capital investments, repaying debt, and possible acquisitions.
  • The offering was conducted under SEC registration and managed by reputable underwriters.

YORK, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- The York Water Company (“York Water” or the “Company”) (NASDAQ: YORW), a provider of water and wastewater utility services, announced today the closing of its previously-announced public offering of 1,521,739 shares of its common stock at a price to the public of $28.50 per share. The net proceeds to York Water from the offering, after deducting the underwriting discounts and commissions and other offering expenses, are approximately $41.4 million.

York Water intends to use the net proceeds from the offering for general corporate purposes, including our capital investment program, repayment of outstanding indebtedness, and potential acquisitions.

Huntington Capital Markets is acting as sole book-running manager and Seaport Global Securities is acting as co-manager for the offering.

The offering was made by means of a prospectus supplement and an accompanying prospectus. A prospectus supplement relating to the offering has been filed with the SEC. Copies of the prospectus supplement and the accompanying prospectus may be obtained by visiting EDGAR on the SEC’s website at www.sec.gov or from: Huntington Securities, Inc., 41 South High Street, Columbus, OH 43215, or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This news release may contain forward-looking statements. The Company undertakes no duty to update any forward-looking statement. More information concerning forward-looking statements can be found in the Company’s filings with the SEC at sec.gov. 


Risks

  • Possible market volatility impacting stock price after the offering.
  • Uncertainties regarding the timing and success of potential acquisitions.
  • General market and regulatory risks associated with water utility sector investments.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026